96. Crohn disease
2,209 clinical trials,   1,276 drugs   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00495521
(ClinicalTrials.gov)
June 200729/6/2007High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in ChildrenA Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's DiseaseCrohn's DiseaseDrug: 4-Aminosalicylic acid extended release granulesJacobus PharmaceuticalNULLTerminated2 Years18 YearsAll2Phase 2United States;Israel
2NCT00417690
(ClinicalTrials.gov)
January 20072/1/2007High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's DiseaseA Prospective Randomized Double-Blind Study of PASER® in the Management of Patients Experiencing an Acute Flare of Crohn's DiseaseCrohn's DiseaseDrug: 4-Aminosalicylic acid;Drug: PASER placebo granulesJacobus PharmaceuticalNULLTerminated18 Years65 YearsBoth54Phase 2United States;Israel
3NCT00004423
(ClinicalTrials.gov)
December 199518/10/1999Controlled Trial of 4-Aminosalicylic Acid in Patients With Small Bowel Crohn's DiseaseCrohn's DiseaseDrug: -aminosalicylic acidUniversity of VermontNULLCompleted18 Years80 YearsBoth80N/ANULL